Canabinoide sintético (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Canabinoide sintético" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

27doi.org

2^nd place

4^th place

24nih.gov

4^th place

8^th place

9web.archive.org

1^st place

4worldcat.org

5^th place

4drugsdata.org

low place

3unodc.org

2,494^th place

1,806^th place

3cdc.gov

218^th place

177^th place

3europa.eu

68^th place

56^th place

2globo.com

62^nd place

2^nd place

2newsweek.com

269^th place

490^th place

2watson.ch

6,345^th place

low place

2archive.today

14^th place

110^th place

2military.com

1,699^th place

3,456^th place

1sagepub.com

731^st place

660^th place

1fbi.gov

881^st place

1,011^th place

1huffingtonpost.com

109^th place

181^st place

1zenodo.org

621^st place

1,847^th place

1drugabuse.gov

6,166^th place

6,156^th place

1fda.gov

447^th place

869^th place

1uniklinik-freiburg.de

low place

1theguardian.com

12^th place

21^st place

1christie.nhs.uk

low place

1metro.co.uk

296^th place

512^th place

1manchestereveningnews.co.uk

675^th place

1,901^st place

1independent.co.uk

36^th place

90^th place

1ghostarchive.org

32^nd place

501^st place

1vice.com

175^th place

294^th place

1itv.com

494^th place

1,868^th place

1lep.co.uk

low place

1thestar.co.uk

5,944^th place

low place

1drugcom.de

low place

1srf.ch

1,487^th place

low place

1news4jax.com

9,316^th place

low place

1apnews.com

129^th place

452^nd place

1dea.gov

8,191^st place

low place

1rnz.co.nz

2,219^th place

6,939^th place

1aacc.org

low place

1opencongress.org

low place

1webmd.com

1,169^th place

809^th place

1usdoj.gov

2,755^th place

4,904^th place

1nctimes.com

low place

1federalregister.gov

2,474^th place

low place

1justice.gov

918^th place

1,762^nd place

1usatoday.com

41^st place

105^th place

1cnn.com

28^th place

50^th place

1msn.com

117^th place

118^th place

1ajc.com

685^th place

1,625^th place

1cadca.org

low place

1timesnews.net

low place

1nytimes.com

7^th place

14^th place

1iowa.gov

8,907^th place

low place

1arkansasonline.com

4,038^th place

low place

1state.or.us

7,635^th place

low place

1newsbythesecond.com

low place

1michigan.gov

4,936^th place

low place

1in.gov

3,146^th place

low place

1wral.com

5,672^nd place

low place

1state.nc.us

low place

1af.mil

439^th place

891^st place

1monitoringthefuture.org

low place

1sciencedirect.com

149^th place

155^th place

aacc.org

«Synthetic Cannabinoids - AACC.org». www.aacc.org. Consultado em 4 de maio de 2018

af.mil

«Air Force officials ban use and possession of Spice, mood-altering substances. Air Force News. June 17, 2010. Accessed: June 18, 2010». Af.mil. Consultado em 19 de junho de 2010. Arquivado do original em 24 de outubro de 2011

ajc.com

Simmons, Andria (24 de maio de 2010). «Governor signs bill to outlaw synthetic marijuana». ajc.com. Consultado em 4 de junho de 2021

apnews.com

«How the Associated Press collected information on CBD-vapes». AP NEWS. 16 de setembro de 2019

archive.today

The Associated Press. How major issues fared in Kansas Legislature. CNBC. May 23, 2010. Accessed: May 23, 2010
Argus Leader, "New law bans synthetic drugs," by John Hult (February 23rd 2012 - retrieved on May 14th, 2012).

arkansasonline.com

Gavin Lesnick (2 de julho de 2010). «Beebe signs emergency ban on K2». Arkansas Online. Arkansas Democrat Gazette. Consultado em 26 de julho de 2010

cadca.org

«Alabama Coalition Gets Salvia and K2 Banned in Their State». CADCA. 20 de maio de 2010. Consultado em 24 de agosto de 2010

cdc.gov

«Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use — United States, January–May 2015». www.cdc.gov (em inglês). 12 de junho de 2015. Consultado em 1 de novembro de 2018
«Frequently Asked Questions | Marijuana | CDC». www.cdc.gov (em inglês). 16 de março de 2018. Consultado em 4 de maio de 2018 10. How harmful is K2/Spice (synthetic marijuana or synthetic cannabinoids)?
Law R, Schier J, Martin C, Chang A, Wolkin A (junho de 2015). «Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015». MMWR. Morbidity and Mortality Weekly Report. 64 (22): 618–9. PMC 4584925. PMID 26068566

christie.nhs.uk

«Health warning issued over fake "THC vape" that contains "spice"». www.christie.nhs.uk

cnn.com

Meserve, Jeanne (28 de fevereiro de 2011). «DEA imposes "emergency" ban to control synthetic marijuana». CNN. Consultado em 1 de março de 2011

dea.gov

«Drug Fact Sheet: Marijuana» (PDF). Drug Enforcement Administration

doi.org

dx.doi.org

Mechoulam, R; Lander, N; Breuer, A; Zahalka, J (1990). «Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative». Tetrahedron: Asymmetry. 1 (5): 315–318. doi:10.1016/S0957-4166(00)86322-3
Seely, Kathryn A.; Lapoint, Jeff; Moran, Jeffery H.; Fattore, Liana (3 de dezembro de 2012). «Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids». Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39 (2): 234–243. ISSN 1878-4216. PMC 3936256. PMID 22561602. doi:10.1016/j.pnpbp.2012.04.017
Riboulet-Zemouli, Kenzi (2020). «'Cannabis' ontologies I: Conceptual issues with Cannabis and cannabinoids terminology». Drug Science, Policy and Law (em inglês). 6: 12, 19. ISSN 2050-3245. doi:10.1177/2050324520945797
Diao X, Huestis MA (fevereiro de 2017). «Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites». Clinical Pharmacology and Therapeutics. 101 (2): 239–253. PMID 27727455. doi:10.1002/cpt.534
Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, et al. (agosto de 2015). «Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135». ACS Chemical Neuroscience (em inglês). 6 (8): 1445–58. PMID 25921407. doi:10.1021/acschemneuro.5b00107
Cannaert A, Storme J, Franz F, Auwärter V, Stove CP (dezembro de 2016). «Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay». Analytical Chemistry (em inglês). 88 (23): 11476–11485. PMID 27779402. doi:10.1021/acs.analchem.6b02600
Abouchedid R, Ho JH, Hudson S, Dines A, Archer JR, Wood DM, Dargan PI (dezembro de 2016). «Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation». Journal of Medical Toxicology. 12 (4): 396–401. PMC 5135680. PMID 27456262. doi:10.1007/s13181-016-0571-7
Spaderna, M; Addy, PH; D'Souza, DC (agosto de 2013). «Spicing things up: Synthetic cannabinoids.». Psychopharmacology. 228 (4): 525–40. PMC 3799955. PMID 23836028. doi:10.1007/s00213-013-3188-4
Fattore L, Fratta W (21 de setembro de 2011). «Beyond THC: The New Generation of Cannabinoid Designer Drugs». Frontiers in Behavioral Neuroscience. 5. 60 páginas. PMC 3187647. PMID 22007163. doi:10.3389/fnbeh.2011.00060
Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (1 de julho de 2013). «Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products». Forensic Toxicology (em inglês). 31 (2): 223–240. ISSN 1860-8965. doi:10.1007/s11419-013-0182-9
Zolot J (março de 2019). «Life-Threatening Bleeding and Deaths from Synthetic Cannabinoids». The American Journal of Nursing. 119 (3). 15 páginas. PMID 30801303. doi:10.1097/01.NAJ.0000554023.28593.fd
European Monitoring Centre for Drugs Drug Addiction (2009). Understanding the 'Spice' phenomenon (PDF). [S.l.]: European Monitoring Centre for Drugs and Drug Addiction. ISBN 9789291684113. ISSN 1725-5767. doi:10.2810/27063. Consultado em 2 de outubro de 2021
Khullar V, Jain A, Sattari M (agosto de 2014). «Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones». Journal of General Internal Medicine. 29 (8): 1200–4. PMC 4099455. PMID 24553958. doi:10.1007/s11606-014-2802-4
Buser GL, Gerona RR, Horowitz BZ, Vian KP, Troxell ML, Hendrickson RG, et al. (agosto de 2014). «Acute kidney injury associated with smoking synthetic cannabinoid». Clinical Toxicology. 52 (7): 664–73. PMID 25089722. doi:10.3109/15563650.2014.932365
Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V (março de 2013). «Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings». Addiction. 108 (3): 534–44. PMID 22971158. doi:10.1111/j.1360-0443.2012.04078.x
Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, Kleinschmidt K (setembro de 2012). «Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation». The American Journal of Emergency Medicine. 30 (7): 1320.e5–7. PMID 21802885. doi:10.1016/j.ajem.2011.05.013
Fattore L (abril de 2016). «Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis». Biological Psychiatry. 79 (7): 539–48. PMID 26970364. doi:10.1016/j.biopsych.2016.02.001
Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS (dezembro de 2013). «Ischemic stroke after use of the synthetic marijuana "spice"». Neurology. 81 (24): 2090–3. PMC 3863350. PMID 24212384. doi:10.1212/01.wnl.0000437297.05570.a2
Giorgetti A, Busardò FP, Tittarelli R, Auwärter V, Giorgetti R (25 de maio de 2020). «Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists». Frontiers in Psychiatry. 11. 464 páginas. PMC 7261860. PMID 32523555. doi:10.3389/fpsyt.2020.00464
Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL (fevereiro de 2014). «Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?». Life Sciences. 97 (1): 45–54. PMC 3945037. PMID 24084047. doi:10.1016/j.lfs.2013.09.017
Fisar Z (junho de 2010). «Inhibition of monoamine oxidase activity by cannabinoids». Naunyn-Schmiedeberg's Archives of Pharmacology. 381 (6): 563–72. PMID 20401651. doi:10.1007/s00210-010-0517-6
Zavitsanou K, Wang H, Dalton VS, Nguyen V (agosto de 2010). «Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats». Neuroscience. 169 (1): 315–24. PMID 20438810. doi:10.1016/j.neuroscience.2010.04.005
Yano H, Adhikari P, Naing S, Hoffman AF, Baumann MH, Lupica CR, Shi L (maio de 2020). «1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans». ACS Chemical Neuroscience. 11 (10): 1400–1405. PMC 8275447. PMID 32324370. doi:10.1021/acschemneuro.0c00034
Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D (fevereiro de 2017). «Focus on cannabinoids and synthetic cannabinoids». Clinical Pharmacology and Therapeutics. 101 (2): 220–229. PMID 27861784. doi:10.1002/cpt.563
Brents LK, Gallus-Zawada A, Radominska-Pandya A, Vasiljevik T, Prisinzano TE, Fantegrossi WE, et al. (abril de 2012). «Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity». Biochemical Pharmacology. 83 (7): 952–61. PMC 3288656. PMID 22266354. doi:10.1016/j.bcp.2012.01.004
Wohlfarth A, Gandhi AS, Pang S, Zhu M, Scheidweiler KB, Huestis MA (fevereiro de 2014). «Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry». Analytical and Bioanalytical Chemistry. 406 (6): 1763–80. PMID 24518903. doi:10.1007/s00216-014-7668-0
Roehler DR, Hoots BE, Vivolo-Kantor AM (fevereiro de 2020). «Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States». Drug and Alcohol Dependence. 207. 107810 páginas. PMID 31862557. doi:10.1016/j.drugalcdep.2019.107810. Consultado em 31 de maio de 2020

drugabuse.gov

archives.drugabuse.gov

«Structure-Activity Relationships of the Cannabinoids» (PDF). NIDA Research Monograph. 79. 1987 – via U.S. Department of Health and Human Services

drugcom.de

«Fake Hanf mit synthetischen Cannabinoiden besprüht - drugcom». www.drugcom.de

drugsdata.org

EcstasyData.org, DrugsData org / Erowid /. «DrugsData.org (formerly EcstasyData): Test Details : Result #6905 - Synthetisches Haschisch, 6905». www.drugsdata.org
EcstasyData.org, DrugsData org / Erowid /. «DrugsData.org (formerly EcstasyData): Test Details : Result #8111 - Haschish, 8111». www.drugsdata.org
EcstasyData.org, DrugsData org / Erowid /. «DrugsData.org (formerly EcstasyData): Test Details : Result #8255 - Fake Hash, 8255». www.drugsdata.org
EcstasyData.org, DrugsData org / Erowid /. «DrugsData.org (formerly EcstasyData): Test Details : Result #8672 - Adulterated Hash, 8672». www.drugsdata.org

europa.eu

emcdda.europa.eu

European Monitoring Centre for Drugs Drug Addiction (2009). Understanding the 'Spice' phenomenon (PDF). [S.l.]: European Monitoring Centre for Drugs and Drug Addiction. ISBN 9789291684113. ISSN 1725-5767. doi:10.2810/27063. Consultado em 2 de outubro de 2021
«Synthetic cannabinoids in Europe | www.emcdda.europa.eu». www.emcdda.europa.eu (em inglês). Consultado em 4 de maio de 2018
European Monitoring Centre for Drugs and Drug Addiction (2009). «Understanding the "Spice" Phenomenon» (PDF). EMCDDA 2009 Thematic Paper

fbi.gov

leb.fbi.gov

Macher, Roland; Burke, Tod W; Owen, Stephen S (1 de maio de 2012). «Synthetic Marijuana». FBI: Law Enforcement Bulletin (em inglês). Consultado em 19 de março de 2020

fda.gov

«Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA» (Nota de imprensa). United States Food and Drug Administration. 19 de julho de 2018

federalregister.gov

«Federal Register - Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I». Federalregister.gov. Março de 2011. Consultado em 20 de fevereiro de 2015

ghostarchive.org

«Schoolchildren collapse after unknowingly inhaling spice vape». The Independent (em inglês). 16 de julho de 2019. Cópia arquivada em 26 de maio de 2022

globo.com

g1.globo.com

«'Hoje em dia está muita gente aí roubando, matando por causa disso', diz usuário sobre droga sintética». G1. Consultado em 5 de outubro de 2022
«Droga K9, que causa 'efeito zumbi', é apreendida em encomenda na Grande Florianópolis». G1. 21 de junho de 2023. Consultado em 12 de julho de 2023

huffingtonpost.com

Science, Live (7 de fevereiro de 2017). «Synthetic Marijuana Linked To Seizures, Psychosis And Death». Huffington Post (em inglês). Consultado em 4 de maio de 2018

in.gov

«Attorney General: Synthetic Drug Enforcement». In.gov. Consultado em 20 de fevereiro de 2015

independent.co.uk

«Schoolchildren collapse after unknowingly inhaling spice vape». The Independent (em inglês). 16 de julho de 2019. Cópia arquivada em 26 de maio de 2022

iowa.gov

legis.iowa.gov

Iowa Code § 124.204(4)(u) (PDF) (defining a Schedule I controlled substance to include "synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant....")

itv.com

«Health warning as nine young people collapse after using 'spice' vape». ITV News (em inglês)

justice.gov

«Drug Scheduling from the US Drug Enforcement Administration website». Justice.gov. Consultado em 19 de junho de 2010. Arquivado do original em 12 de janeiro de 2012

lep.co.uk

«Health warning as nine youths collapse after using 'spice' vape». www.lep.co.uk (em inglês)

manchestereveningnews.co.uk

Day, Rebecca (16 de julho de 2019). «Schoolchildren have collapsed after vaping Spice». men

metro.co.uk

«Eight pupils collapse after vaping Spice missold as THC vape». Metro (em inglês). 17 de dezembro de 2019

michigan.gov

«LARA - Snyder signs bill to classify K2, Spice as Schedule 1 drugs». Michigan.gov. Consultado em 20 de fevereiro de 2015

military.com

monitoringthefuture.org

«Monitoring the Future Table 2: Trends in Annual Prevalence of Use of Various Drugs» (PDF)

msn.com

today.msnbc.msn.com

«The big business of synthetic highs». TODAY.com. Consultado em 20 de fevereiro de 2015. Arquivado do original em 25 de junho de 2011

nctimes.com

Cook, Morgan (28 de fevereiro de 2011). «Synthetic marijuana illegal as of Tuesday». North County Times. San Diego. Consultado em 28 de fevereiro de 2011. Arquivado do original em 3 de março de 2011

news4jax.com

Harris, Jenese (22 de setembro de 2020). «Calls about poisonings from fake marijuana edibles, candy triple». WJXT (em inglês)

newsbythesecond.com

Daniel Martynowicz. «Illinois Bans Synthetic Cannabinoids». Consultado em 14 de setembro de 2010. Arquivado do original em 6 de setembro de 2010

newsweek.com

«K2: Scary Drug or Another Drug Scare?». Newsweek (em inglês). 3 de março de 2010. Consultado em 4 de maio de 2018
«Synthetic Marijuana Deaths Tripled This Year». Newsweek (em inglês). 11 de junho de 2015. Consultado em 5 de maio de 2018

nih.gov

ncbi.nlm.nih.gov

Seely, Kathryn A.; Lapoint, Jeff; Moran, Jeffery H.; Fattore, Liana (3 de dezembro de 2012). «Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids». Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39 (2): 234–243. ISSN 1878-4216. PMC 3936256. PMID 22561602. doi:10.1016/j.pnpbp.2012.04.017
Diao X, Huestis MA (fevereiro de 2017). «Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites». Clinical Pharmacology and Therapeutics. 101 (2): 239–253. PMID 27727455. doi:10.1002/cpt.534
Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, et al. (agosto de 2015). «Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135». ACS Chemical Neuroscience (em inglês). 6 (8): 1445–58. PMID 25921407. doi:10.1021/acschemneuro.5b00107
Cannaert A, Storme J, Franz F, Auwärter V, Stove CP (dezembro de 2016). «Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay». Analytical Chemistry (em inglês). 88 (23): 11476–11485. PMID 27779402. doi:10.1021/acs.analchem.6b02600
Abouchedid R, Ho JH, Hudson S, Dines A, Archer JR, Wood DM, Dargan PI (dezembro de 2016). «Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation». Journal of Medical Toxicology. 12 (4): 396–401. PMC 5135680. PMID 27456262. doi:10.1007/s13181-016-0571-7
Spaderna, M; Addy, PH; D'Souza, DC (agosto de 2013). «Spicing things up: Synthetic cannabinoids.». Psychopharmacology. 228 (4): 525–40. PMC 3799955. PMID 23836028. doi:10.1007/s00213-013-3188-4
Fattore L, Fratta W (21 de setembro de 2011). «Beyond THC: The New Generation of Cannabinoid Designer Drugs». Frontiers in Behavioral Neuroscience. 5. 60 páginas. PMC 3187647. PMID 22007163. doi:10.3389/fnbeh.2011.00060
Zolot J (março de 2019). «Life-Threatening Bleeding and Deaths from Synthetic Cannabinoids». The American Journal of Nursing. 119 (3). 15 páginas. PMID 30801303. doi:10.1097/01.NAJ.0000554023.28593.fd
Law R, Schier J, Martin C, Chang A, Wolkin A (junho de 2015). «Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015». MMWR. Morbidity and Mortality Weekly Report. 64 (22): 618–9. PMC 4584925. PMID 26068566
Khullar V, Jain A, Sattari M (agosto de 2014). «Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones». Journal of General Internal Medicine. 29 (8): 1200–4. PMC 4099455. PMID 24553958. doi:10.1007/s11606-014-2802-4
Buser GL, Gerona RR, Horowitz BZ, Vian KP, Troxell ML, Hendrickson RG, et al. (agosto de 2014). «Acute kidney injury associated with smoking synthetic cannabinoid». Clinical Toxicology. 52 (7): 664–73. PMID 25089722. doi:10.3109/15563650.2014.932365
Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V (março de 2013). «Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings». Addiction. 108 (3): 534–44. PMID 22971158. doi:10.1111/j.1360-0443.2012.04078.x
Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, Kleinschmidt K (setembro de 2012). «Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation». The American Journal of Emergency Medicine. 30 (7): 1320.e5–7. PMID 21802885. doi:10.1016/j.ajem.2011.05.013
Fattore L (abril de 2016). «Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis». Biological Psychiatry. 79 (7): 539–48. PMID 26970364. doi:10.1016/j.biopsych.2016.02.001
Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS (dezembro de 2013). «Ischemic stroke after use of the synthetic marijuana "spice"». Neurology. 81 (24): 2090–3. PMC 3863350. PMID 24212384. doi:10.1212/01.wnl.0000437297.05570.a2
Giorgetti A, Busardò FP, Tittarelli R, Auwärter V, Giorgetti R (25 de maio de 2020). «Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists». Frontiers in Psychiatry. 11. 464 páginas. PMC 7261860. PMID 32523555. doi:10.3389/fpsyt.2020.00464
Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL (fevereiro de 2014). «Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?». Life Sciences. 97 (1): 45–54. PMC 3945037. PMID 24084047. doi:10.1016/j.lfs.2013.09.017
Fisar Z (junho de 2010). «Inhibition of monoamine oxidase activity by cannabinoids». Naunyn-Schmiedeberg's Archives of Pharmacology. 381 (6): 563–72. PMID 20401651. doi:10.1007/s00210-010-0517-6
Zavitsanou K, Wang H, Dalton VS, Nguyen V (agosto de 2010). «Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats». Neuroscience. 169 (1): 315–24. PMID 20438810. doi:10.1016/j.neuroscience.2010.04.005
Yano H, Adhikari P, Naing S, Hoffman AF, Baumann MH, Lupica CR, Shi L (maio de 2020). «1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans». ACS Chemical Neuroscience. 11 (10): 1400–1405. PMC 8275447. PMID 32324370. doi:10.1021/acschemneuro.0c00034
Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D (fevereiro de 2017). «Focus on cannabinoids and synthetic cannabinoids». Clinical Pharmacology and Therapeutics. 101 (2): 220–229. PMID 27861784. doi:10.1002/cpt.563
Brents LK, Gallus-Zawada A, Radominska-Pandya A, Vasiljevik T, Prisinzano TE, Fantegrossi WE, et al. (abril de 2012). «Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity». Biochemical Pharmacology. 83 (7): 952–61. PMC 3288656. PMID 22266354. doi:10.1016/j.bcp.2012.01.004
Wohlfarth A, Gandhi AS, Pang S, Zhu M, Scheidweiler KB, Huestis MA (fevereiro de 2014). «Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry». Analytical and Bioanalytical Chemistry. 406 (6): 1763–80. PMID 24518903. doi:10.1007/s00216-014-7668-0
Roehler DR, Hoots BE, Vivolo-Kantor AM (fevereiro de 2020). «Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States». Drug and Alcohol Dependence. 207. 107810 páginas. PMID 31862557. doi:10.1016/j.drugalcdep.2019.107810. Consultado em 31 de maio de 2020

nytimes.com

Gay, Malcolm. (2010-07-10) Synthetic Marijuana Spurs State Bans. New York Times. Retrieved on August 7, 2011.

opencongress.org

«The David Mitchell Rozga Act (S.605 - Dangerous Synthetic Drug Control Act of 2011)». Opencongress.org. Consultado em 9 de setembro de 2012. Arquivado do original em 23 de agosto de 2012

rnz.co.nz

«Huge jump in synthetic cannabis deaths - coroner». 27 de julho de 2018. Consultado em 30 de maio de 2020

sagepub.com

journals.sagepub.com

Riboulet-Zemouli, Kenzi (2020). «'Cannabis' ontologies I: Conceptual issues with Cannabis and cannabinoids terminology». Drug Science, Policy and Law (em inglês). 6: 12, 19. ISSN 2050-3245. doi:10.1177/2050324520945797

sciencedirect.com

Roehler DR, Hoots BE, Vivolo-Kantor AM (fevereiro de 2020). «Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States». Drug and Alcohol Dependence. 207. 107810 páginas. PMID 31862557. doi:10.1016/j.drugalcdep.2019.107810. Consultado em 31 de maio de 2020

srf.ch

«Tödlicher Fake Hanf - Chemisch behandelte Hanfblüten – niemand kann sie erkennen». Schweizer Radio und Fernsehen (SRF) (em alemão). 14 de agosto de 2020

state.nc.us

ncga.state.nc.us

«Make Synthetic Cannabinoids Illegal» (PDF). General Assembly of North Carolina. 31 de janeiro de 2011. Consultado em 27 de setembro de 2012

state.or.us

pharmacy.state.or.us

«Synthetic Cannabis — Controlled Substance Information». Consultado em 16 de outubro de 2010

theguardian.com

McLennan, William (22 de setembro de 2018). «Vapers tricked into buying synthetic cannabis-laced product». The Observer

thestar.co.uk

«Health warning as nine youths collapse after using 'Spice' vape». www.thestar.co.uk (em inglês)

timesnews.net

«TN police, laws try to keep up with synthetic drug chemists». Timesnews.net. Consultado em 29 de outubro de 2017

uniklinik-freiburg.de

Angerer, Verena; Moosman, Bjoern; Franz, Florian; Auwärter, Volker (2015). «5F-cumyl-PINACA in 'e-liquids' for electronic cigarettes – A new type of synthetic cannabinoid in a trendy product» (PDF). Consultado em 14 de junho de 2018

unodc.org

UNODC, Laboratory & Scientific Service. «Details for Synthetic cannabinoids». United Nations Office on Drugs and Crime. Consultado em 17 de outubro de 2021 ^{[ligação inativa]}
«Synthetic Cannabinoids in Herbal Products» (PDF). United Nations Office on Drugs and Crime
«Details for Synthetic cannabinoids». www.unodc.org (em inglês). Consultado em 4 de maio de 2018

usatoday.com

Donna Leinwand (24 de maio de 2010). «Places race to outlaw K2 'Spice' drug». USA Today. Consultado em 26 de julho de 2010

usdoj.gov

deadiversion.usdoj.gov

«HU-210». USDOJ.gov. Consultado em 16 de setembro de 2010. Arquivado do original em 7 de outubro de 2010

vice.com

Tahsin, Jamie (10 de dezembro de 2019). «If You Buy Weed Vapes in the UK, Beware – But Not for the Reason You Think». Vice (em inglês)

watson.ch

«Fake Hanf: Ein Drogentrend schwappt in die Schweiz – was du darüber wissen musst». watson.ch (em alemão)
«Fake Hanf: Tödliches Marihuana hat bereits 61 Menschen getötet». watson.ch (em alemão)

web.archive.org

«The David Mitchell Rozga Act (S.605 - Dangerous Synthetic Drug Control Act of 2011)». Opencongress.org. Consultado em 9 de setembro de 2012. Arquivado do original em 23 de agosto de 2012
«HU-210». USDOJ.gov. Consultado em 16 de setembro de 2010. Arquivado do original em 7 de outubro de 2010
Cook, Morgan (28 de fevereiro de 2011). «Synthetic marijuana illegal as of Tuesday». North County Times. San Diego. Consultado em 28 de fevereiro de 2011. Arquivado do original em 3 de março de 2011
«Drug Scheduling from the US Drug Enforcement Administration website». Justice.gov. Consultado em 19 de junho de 2010. Arquivado do original em 12 de janeiro de 2012
«The big business of synthetic highs». TODAY.com. Consultado em 20 de fevereiro de 2015. Arquivado do original em 25 de junho de 2011
Daniel Martynowicz. «Illinois Bans Synthetic Cannabinoids». Consultado em 14 de setembro de 2010. Arquivado do original em 6 de setembro de 2010
Allan, David; Fisher, Cindy. Ruling Clarifies 'Legal' Drug Policy. Stars and Stripes via Military.com. May 23, 2010. Accessed: May 23, 2010 Arquivado em 2010-06-06 no Wayback Machine
Marines Ban Spice Drug. Military.com. May 23, 2010. Accessed: May 23, 2010 Arquivado em 2010-06-06 no Wayback Machine
«Air Force officials ban use and possession of Spice, mood-altering substances. Air Force News. June 17, 2010. Accessed: June 18, 2010». Af.mil. Consultado em 19 de junho de 2010. Arquivado do original em 24 de outubro de 2011

webmd.com

Vashi, Sonam (26 de setembro de 2012). «K2 Trend Not Slowing Down»

worldcat.org

Seely, Kathryn A.; Lapoint, Jeff; Moran, Jeffery H.; Fattore, Liana (3 de dezembro de 2012). «Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids». Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39 (2): 234–243. ISSN 1878-4216. PMC 3936256. PMID 22561602. doi:10.1016/j.pnpbp.2012.04.017
Riboulet-Zemouli, Kenzi (2020). «'Cannabis' ontologies I: Conceptual issues with Cannabis and cannabinoids terminology». Drug Science, Policy and Law (em inglês). 6: 12, 19. ISSN 2050-3245. doi:10.1177/2050324520945797
Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (1 de julho de 2013). «Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products». Forensic Toxicology (em inglês). 31 (2): 223–240. ISSN 1860-8965. doi:10.1007/s11419-013-0182-9
European Monitoring Centre for Drugs Drug Addiction (2009). Understanding the 'Spice' phenomenon (PDF). [S.l.]: European Monitoring Centre for Drugs and Drug Addiction. ISBN 9789291684113. ISSN 1725-5767. doi:10.2810/27063. Consultado em 2 de outubro de 2021

wral.com

«NC Senate OKs synthetic pot ban». WRAL-TV. 10 de fevereiro de 2011. Consultado em 27 de setembro de 2012

zenodo.org

Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, et al. (agosto de 2015). «Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135». ACS Chemical Neuroscience (em inglês). 6 (8): 1445–58. PMID 25921407. doi:10.1021/acschemneuro.5b00107